Crinetics (CRNX) is up 14.7%, or $6.75 to $52.70.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRNX:
- Midday Fly By: Warner Bros. urges holders to reject Paramount bid
- Crinetics rises 12.8%
- Crinetics 7.62M share Secondary priced at $45.95
- Crinetics Highlights Strong PALSONIFY Launch and Trial Progress
- Crinetics Buy Rating: Derisked Atumelnant CAH Program and Outperforming Palsonify Launch Signal Undervalued Shares